Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02160392 · ClinicalTrials.gov registry record
Female Upper Genital Tract in HIV-infected Women
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 26
- Enrollment target
NCT02160392: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT02160392 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02160392 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The female upper genital tract is a unique compartment involved in HIV pathogenesis.
Primary Outcome
Endometrial lavage (EML) and biopsy (EMB) samples were compared to cervicovaginal lavage (CVL) and fluid (CVF) samples from HIV-negative healthy women (N=x) and HIV-infected women (n=x) taking ART with plasma HIV RNA \<40 copies/mL. All participants were in the luteal phase of the menstrual cycle. Immunologic study was completed using Luminex and flow cytometry. Concentrations of tenofovir (TFV), emtricitabine (FTC) and their active intracellular metabolites (TFVdp and FTCtp) were measured using
Interventions
- PROCEDURE Endometrial biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2010-05 |
| Est. Completion | 2014-03 |
What the finished NCT02160392 record still lists
NCT02160392 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Endometrial biopsy is the first listed.
NCT02160392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02160392 about?
NCT02160392 is a clinical study titled "Female Upper Genital Tract in HIV-infected Women". The female upper genital tract is a unique compartment involved in HIV pathogenesis.
What is the current status of trial NCT02160392?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2010-05. Estimated completion is 2014-03.
What interventions are being tested in trial NCT02160392?
The interventions under investigation include: Endometrial biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02160392?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia